Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 16 clinical trials
Drug-eluting Balloon for Treatment of Non-atherosclerotic Renal Artery Stenosis

Efficacy of drug eluting balloon(DEB) for non-atherosclerotic renal artery stenosis will be tested in this study. The intervention group will be treated with paclitaxel eluting balloon. The control group will be treated with plain old balloon(POB). The primary endpoint is efficacy of blood pressure control.

  • 0 views
  • 24 Jan, 2021
  • 1 location
Predictive Multimodal MRI Factors in Subacute Cerebral Artery Occlusiontreated by Thrombectomy (PIMISUTT) (PIMISUTT)

Our study aims to measure metabolic and functional parameters of the infarcted territory by multimodal cerebral MRI in patients diagnosed with unilateral proximal occlusion of the middle cerebral artery and treated by thrombectomy in order to correlate those parameters to clinical outcome (evaluated by modified Rankin score) at 3 months. …

  • 0 views
  • 27 Apr, 2022
  • 1 location
Patient Specific Biomechanical Modeling of Abdominal Aortic Aneurysm to Improve Aortic Endovascular Repair (AAA2D3DIII)

behaviour based on participant specific parameters. The results of this research will provide the Canadian industry with the first realistic deformable vascular geometry tool for live endovascular

abdominal aortic aneurysm
aortic aneurysm
  • 7 views
  • 05 Mar, 2022
  • 1 location
Appraising the Embolization of Aneurysms Using Balt Optima™ Coil System (APPLY Study) (APPLY)

In recent years, many developments have been made to the tools and techniques used to treat IAs via endovascular intervention. Specifically, to the detachable coils themselves. In March 2018

intracranial aneurysm
embolization procedure
detachment
  • 305 views
  • 12 May, 2022
  • 1 location
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-1)

To evaluate the safety and efficacy of recombinant human hepatocyte growth factor (HGF) bare plasmid injection for local intramuscular injection in the treatment of patients with severe lower limb hemorrhagic disease (Rutherford grade 4)

ischemia
stenosis
critical limb ischemia
gene therapy
hepatocyte growth factor
  • 10 views
  • 22 Apr, 2022
  • 11 locations
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-2)

The purpose of this study is to evaluate whether intramuscular injections of NL003 into the calf is safe and effective in the treatment of critical limb ischemia

ischemia
stenosis
ischemic ulcer
gene therapy
critical limb ischaemia
  • 2 views
  • 20 Apr, 2022
  • 12 locations
ACtive Catheterization for EndovaScular TreatmentS (ACCESS)

The objective of this clinical investigation is to evaluate the safety and technical success of the Basecamp Vascular controllable directional GECKO guidewire when used to facilitate endovascular access to the targeted vessel in order to treat the vascular lesion.

stenosis
  • 0 views
  • 28 Jul, 2022
  • 1 location
The Intra-arterial Vasospasm Trial (iVAST)

The primary objective of the study is to determine the optimal intra-arterial drug treatment regimen for arterial lumen restoration post cerebral vasospasm following aneurysmal subarachnoid hemorrhage. The secondary objective is to evaluate clinical outcome at 90 days post discharge following optimal intra-arterial drug treatment for cerebral vasospasm. We hypothesize that …

  • 9 views
  • 21 Mar, 2022
  • 3 locations
The Value of Screening for HPR in Patients Undergoing Lower Extremity Arterial Endovascular Interventions

This is a randomized controlled trial designed to evaluate the role of screening for and intervening on patients with high on treatment platelet reactivity undergoing lower extremity arterial endovascular interventions.

arteriopathy
arterial disease
endovascular intervention
ticagrelor
vascular disease
  • 1 views
  • 14 Jun, 2022
  • 1 location
The DETECT Project (DETECT)

This study aims to assess the all-cause mortality at 2 years of patients treated by a paclitaxel drug-eluting devices or non-drug-eluting devices after an endovascular femoropopliteal artery revascularization based on the French National Healthcare Data System (SNDS).

  • 0 views
  • 13 May, 2022
  • 1 location